Healthcare


 Why CSL (ASX:CSL) Is Testing ASX Healthcare Stocks Now

Why CSL (ASX:CSL) Is Testing ASX Healthcare Stocks Now

July 02, 2026 10:58 AM AEST| By Sam

ASX healthcare stocks are drawing fresh attention as CSL, Cochlear, ResMed, Sonic Healthcare and Pro Medicus frame a rebound being tested for durability.

 AdAlta (ASX:1AD) Expands Capital Base With New Shares and Options

AdAlta (ASX:1AD) Expands Capital Base With New Shares and Options

July 02, 2026 10:27 AM AEST| By Sam

AdAlta has applied to quote a substantial issue of new shares and options on the ASX, enhancing financial flexibility while supporting the continued development of its biotechnology pipeline.

 CSL(ASX:CSL)  and Cochlear (ASX:COH) Healthcare Rebound: Is the Recovery Real?

CSL(ASX:CSL) and Cochlear (ASX:COH) Healthcare Rebound: Is the Recovery Real?

July 01, 2026 10:22 PM AEST| By Sam

CSL and Cochlear are back in focus as Australia’s healthcare sector rebounds, with renewed attention on whether the recovery can continue.

 ResMed (ASX:RMD) Pushes Back Against GLP-One Market Fears

ResMed (ASX:RMD) Pushes Back Against GLP-One Market Fears

July 01, 2026 10:21 PM AEST| By Sam

ResMed’s latest performance has challenged concerns around GLP-One medicines, showing continued strength in sleep healthcare demand while the market watches future industry changes.

 Best Health Stocks to Watch for July 2026

Best Health Stocks to Watch for July 2026

July 01, 2026 05:47 PM AEST| By Sam

ASX healthcare stocks remain in focus for July as biotechnology, diagnostics and medical technology trends keep CSL, Sonic Healthcare, TELIX Pharmaceuticals, Ansell, EBOS Group and Mesoblast on the market radar.

 Why Is CSL (ASX:CSL) Reviving Healthcare Stocks?

Why Is CSL (ASX:CSL) Reviving Healthcare Stocks?

July 01, 2026 03:22 PM AEST| By Sam

ASX healthcare stocks are back under review as CSL, Cochlear and ResMed face closer focus on clinical demand, margin repair and global reimbursement.

 ResMed (ASX:RMD): Why Are Healthcare Stocks Under Watch?

ResMed (ASX:RMD): Why Are Healthcare Stocks Under Watch?

July 01, 2026 03:22 PM AEST| By Sam

ASX healthcare stocks face a sharper new financial year test as margin repair, clinical demand and reimbursement settings reshape major healthcare leaders.

 Ramsay Health Care (ASX:RHC): Why Are Healthcare Stocks Back in Focus?

Ramsay Health Care (ASX:RHC): Why Are Healthcare Stocks Back in Focus?

July 01, 2026 03:22 PM AEST| By Sam

ASX healthcare stocks are being assessed through margin repair, clinical demand, diagnostic volume and global reimbursement as Ramsay, Telix and Pro Medicus shape the sector discussion.

 Why Healthcare Stocks Like Pro Medicus (ASX:PME) And CSL (ASX:CSL) Are Bouncing Back

Why Healthcare Stocks Like Pro Medicus (ASX:PME) And CSL (ASX:CSL) Are Bouncing Back

July 01, 2026 01:40 PM AEST| By Sam

Healthcare stocks rebounded strongly as Pro Medicus, CSL, Ramsay Health Care and Sonic Healthcare recovered, while Echo IQ, Biome Australia and Memphasys delivered notable corporate developments supporting sector momentum.

 Amcor (ASX:AMC) or Sonic Healthcare (ASX:SHL): Which ASX Share Looks More Compelling Right Now?

Amcor (ASX:AMC) or Sonic Healthcare (ASX:SHL): Which ASX Share Looks More Compelling Right Now?

July 01, 2026 11:22 AM AEST| By Sam

Amcor and Sonic Healthcare continue attracting attention through global operations, diversified revenue streams and resilient business models as packaging innovation and healthcare demand remain long-term structural growth themes.

 Kalina Power (ASX:KPO), Mitchell Services (ASX:MSV) and Sigma Healthcare (ASX:SIG): Why These ASX Stocks Are Gaining Attention

Kalina Power (ASX:KPO), Mitchell Services (ASX:MSV) and Sigma Healthcare (ASX:SIG): Why These ASX Stocks Are Gaining Attention

July 01, 2026 11:03 AM AEST| By Sam

Kalina Power, Mitchell Services and Sigma Healthcare remain under market attention through improving financial resilience, disciplined balance sheet management and continued operational progress across Australia's energy, mining and healthcare sector...

 Why Is 4DMedical (ASX:4DX) Leading the ASX 200 FY26 Winners?

Why Is 4DMedical (ASX:4DX) Leading the ASX 200 FY26 Winners?

July 01, 2026 09:48 AM AEST| By Sam

Australia's latest financial year highlighted contrasting sector performance, with mining supporting the broader market while 4DMedical gained attention through regulatory progress, commercial expansion and healthcare technology innovation.

 CSL (ASX:CSL) Shares Back in Focus as Healthcare Giant Rebuilds

CSL (ASX:CSL) Shares Back in Focus as Healthcare Giant Rebuilds

June 30, 2026 10:47 PM AEST| By Sam

CSL is regaining attention as its resilient plasma franchise, steady underlying earnings and ongoing restructuring reinforce the company's position as one of Australia's leading healthcare businesses despite near-term operational challenges.

 Why Are CSL (ASX:CSL) Shares Rallying as Healthcare Roars Back?

Why Are CSL (ASX:CSL) Shares Rallying as Healthcare Roars Back?

June 30, 2026 10:20 PM AEST| By Vivek Singh

CSL led Australia's healthcare rebound as capital shifted away from resource companies into defensive growth businesses, placing renewed attention on restructuring progress and the sector's improving market sentiment.

 Why Pro Medicus (ASX:PME) Is Back in Focus After a Landmark US Deal

Why Pro Medicus (ASX:PME) Is Back in Focus After a Landmark US Deal

June 30, 2026 10:19 PM AEST| By Vivek Singh

Pro Medicus strengthened its position in healthcare technology after expanding a major US contract, reinforcing the success of its Visage Seven platform and highlighting continued momentum across large American healthcare networks.

 Why Is Pro Medicus (ASX:PME) Testing Healthcare Stocks?

Why Is Pro Medicus (ASX:PME) Testing Healthcare Stocks?

June 30, 2026 03:31 PM AEST| By Sam

ASX healthcare stocks are facing a clinical validation test as regulatory progress, specialist technology and rare-disease updates place execution quality back in focus.

 Why Is CSL (ASX:CSL) Central to Healthcare Rebound?

Why Is CSL (ASX:CSL) Central to Healthcare Rebound?

June 30, 2026 03:31 PM AEST| By Sam

ASX healthcare stocks are being tested through quality rebound, with earnings confidence, clinical credibility and margin discipline shaping the latest market screen.

 Why Is Pro Medicus (ASX:PME) Driving the Diagnostics Shift in ASX Healthcare Stocks?

Why Is Pro Medicus (ASX:PME) Driving the Diagnostics Shift in ASX Healthcare Stocks?

June 30, 2026 03:31 PM AEST| By Sam

Australia's healthcare sector is increasingly defined by diagnostics, medical imaging and workflow technology, with leading healthcare companies demonstrating how innovation and commercial execution continue reshaping industry attention.

 Epiminder (ASX:EPI): Cash Position Remains Under Market Spotlight

Epiminder (ASX:EPI): Cash Position Remains Under Market Spotlight

June 30, 2026 10:08 AM AEST| By Sam

Epiminder continues advancing its healthcare technology platform while maintaining financial flexibility, with cash management, product development and commercial execution remaining central to its long-term growth strategy.

 CSL (ASX:CSL): Are AI Imaging Deals Changing Healthcare Valuations?

CSL (ASX:CSL): Are AI Imaging Deals Changing Healthcare Valuations?

June 29, 2026 04:41 PM AEST| By Sam

ASX healthcare stocks are being assessed through AI imaging partnerships, commercial channels, clinical progress and defensive earnings as medical technology becomes a sharper valuation signal.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.